Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1) (EXPECT-1)
Pilot Study to Assess Success Factors and Barriers for Preparation of a Phase 3 Study With ExPEC10V in Adults Aged 60 Years or Older and in Stable Health
Sponsor: Innovative Medicines Initiative
A observational or N/A phase clinical study on E.Coli Infections, this trial is completed. The trial is conducted by Innovative Medicines Initiative and has accumulated 13 data snapshots since 2019. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2021 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
May 2021 — Oct 2021 [monthly]
Active Not Recruiting
▶ Show 8 earlier versions
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Apr 2020 — Dec 2020 [monthly]
Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Recruiting
-
Dec 2019 — Jan 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2019 — Dec 2019 [monthly]
Not Yet Recruiting
First recorded
Sep 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Innovative Medicines Initiative
- Janssen Research & Development, LLC
- MJM Bonten
For direct contact, visit the study record on ClinicalTrials.gov .